Corporate Tech Investors

Shanghai Sinobioway Sunterra Biotechnology

Shanghai Sinobioway Sunterra Biotechnology is a corporate venture capital group that makes strategic investments in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Shanghai Sinobioway Sunterra Biotechnology Co., Ltd., a company incorporated in Shanghai in 2016. Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically field of adoptive cellular therapies. The core business of the company is to sublicense the CAB-CAR-T technology in Greater China from F1 Oncology.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/9/2018

Transaction History

Our records indicate that Shanghai Sinobioway Sunterra Biotechnology invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Founder

Wu Zili

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Shanghai Sinobioway Sunterra Biotechnology has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Shanghai New Culture Media Group | ShangPharma Investment Group

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary